Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also play a ...

Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, damaging the myelin, the protective layer of nerve fibers. This damage disrupts communication between ...

Misdiagnoses of multiple sclerosis (MS) represent one of the prominent challenges in MS for patients, clinicians, and researchers. A variety of factors influence misdiagnosis, including testing ...

The science behind multiple sclerosis (MS) changes so rapidly that people with the condition, their families, and even their doctors might not be up to speed with all of the latest news about it. But ...

A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are autoimmune disorders that affect the nervous system. Although they have some shared symptoms, they are unique conditions. MS is a chronic ...

In relapse-remitting multiple sclerosis (MS), people experience periods of high MS activity where they have more symptoms or imaging tests show inflammation. Between these periods, the condition might ...

Multiple sclerosis (MS) and muscular dystrophy (MD) have distinct differences. MS affects the protective covering around nerve fibers, while MD affects the muscle fibers. The causes of MS and MD are ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...